These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

125 related items for PubMed ID: 7123512

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Antithrombin III Northwick Park: demonstration of an inactive high MW complex with increased affinity for heparin.
    Lane DA, Flynn A, Ireland H, Erdjument H, Samson D, Howarth D, Thompson E.
    Br J Haematol; 1987 Apr; 65(4):451-6. PubMed ID: 3580302
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Simultaneous isolation and partial characterization of antithrombin III and alpha 1-proteinase inhibitor from horse plasma.
    Kurdowska A, Koj A, Jaśkowska M.
    Acta Biochim Pol; 1982 Apr; 29(1-2):95-103. PubMed ID: 6983800
    [No Abstract] [Full Text] [Related]

  • 6. Inhibition of urokinase by complex formation with human antithrombin III in absence and presence of heparin.
    Clemmensen I.
    Thromb Haemost; 1978 Jun 30; 39(3):616-23. PubMed ID: 705690
    [Abstract] [Full Text] [Related]

  • 7. Purification of antithrombin 'Vicenza': a molecule with normal heparin affinity and impaired reactivity to thrombin.
    Finazzi G, Tran TH, Barbui T, Duckert F.
    Br J Haematol; 1985 Feb 30; 59(2):259-63. PubMed ID: 3970857
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Heterogeneity of mammalian antithrombin III].
    Bashkov GV, Kalishevskaia TM, Strukova SM.
    Biokhimiia; 1989 Nov 30; 54(11):1797-803. PubMed ID: 2627551
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. A simple two-step isolation procedure for human and bovine antithrombin II/III (heparin cofactor): a comparison of two methods.
    Thaler E, Schmer G.
    Br J Haematol; 1975 Oct 30; 31(2):233-43. PubMed ID: 53066
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Separation of active and inactive forms of human antithrombin by heparin affinity chromatography.
    Heger A, Grunert T, Schulz P, Josic D, Buchacher A.
    Thromb Res; 2002 Apr 15; 106(2):157-64. PubMed ID: 12182916
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Isolation and characteristics of antithrombin III from human plasma].
    Markova OA, Kalashnikov VV, Khvatov VB.
    Vopr Med Khim; 1987 Apr 15; 33(3):62-6. PubMed ID: 3630019
    [Abstract] [Full Text] [Related]

  • 17. Antithrombin III deficiency: decreased synthesis of a biochemically normal molecule.
    Ambruso DR, Leonard BD, Bies RD, Jacobson L, Hathaway WE, Reeve EB.
    Blood; 1982 Jul 15; 60(1):78-83. PubMed ID: 7082848
    [Abstract] [Full Text] [Related]

  • 18. Abnormal antithrombin III with defective serine protease binding (antithrombin III "Denver").
    Sambrano JE, Jacobson LJ, Reeve EB, Manco-Johnson MJ, Hathaway WE.
    J Clin Invest; 1986 Mar 15; 77(3):887-93. PubMed ID: 3512602
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.